508
Participants
Start Date
April 30, 2002
Study Completion Date
May 31, 2007
capecitabine
gemcitabine hydrochloride
Royal United Hospital, Bath
Royal Bournemouth Hospital, Bournemouth
Bristol Haematology and Oncology Centre, Bristol
Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust, Cambridge
Derbyshire Royal Infirmary, Derby
Royal Devon and Exeter Hospital, Exeter
Ipswich Hospital NHS Trust, Ipswich
Queen Elizabeth Hospital, Kings Lynn
Cookridge Hospital at Leeds Teaching Hospital NHS Trust, Leeds
Leicester Royal Infirmary, Leicester
Lincoln County Hospital, Lincoln
Cancer Research UK Liverpool Cancer Trials Unit, Liverpool
Royal Liverpool University Hospital, Liverpool
St. Thomas' Hospital, London
Christie Hospital NHS Trust, Manchester
Clatterbridge Centre for Oncology NHS Trust, Merseyside
James Cook University Hospital at South Tees Hospitals NHS Trust, Middlesbrough, Cleveland
Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle upon Tyne
Norfolk and Norwich University Hospital, Norwich
Derriford Hospital, Plymouth
Poole Hospital NHS Trust, Poole Dorset
Whiston Hospital, Prescot Merseyside
Royal Preston Hospital, Preston
Salisbury District Hospital, Salisbury
Royal South Hants Hospital, Southampton
University Hospital of North Staffordshire, Stoke-on-Trent
Royal Marsden NHS Foundation Trust - Surrey, Sutton
Warrington Hospital NHS Trust, Warrington
Aberdeen Royal Infirmary, Aberdeen
Singleton Hospital of the Swansea NHS Trust, Swansea
Lead Sponsor
Cancer Research UK
OTHER